See more : Shengda Resources Co.,Ltd. (000603.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Kazia Therapeutics Limited (KZA.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kazia Therapeutics Limited, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- CPPGroup Plc (CPP.L) Income Statement Analysis – Financial Results
- Generic Gold Corp. (GGCPF) Income Statement Analysis – Financial Results
- Ensurance Limited (ENA.AX) Income Statement Analysis – Financial Results
- International Business Machines Corporation (IBM.L) Income Statement Analysis – Financial Results
- Baidu, Inc. (BIDU) Income Statement Analysis – Financial Results
Kazia Therapeutics Limited (KZA.AX)
About Kazia Therapeutics Limited
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. The company was incorporated in 1994 and is based in Sydney, Australia.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 555.00 | 10.00K | 15.18M | 988.11K | 1.44M | 3.00M | 8.79M | 3.27M | 89.00K | 87.00K | 1.07M | 2.45M | 2.03M | 9.91M | 11.15M | 13.28M | 17.31M | 13.50M | 17.61M | 16.35M | 32.93M | 19.59M | 58.91M | 26.75M | 19.32M |
| Cost of Revenue | 0.00 | 0.00 | 289.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -44.68K | 0.00 | 0.00 | 2.22M | 2.52M | 4.09M | 6.95M | 5.45M | 4.65M | 4.72M | 7.17M | 7.59M | 100.82M | 7.11M | 31.76M |
| Gross Profit | 555.00 | 10.00K | 15.18M | 988.11K | 1.44M | 3.00M | 8.79M | 3.27M | 89.00K | 87.00K | 1.11M | 2.45M | 2.03M | 7.69M | 8.62M | 9.19M | 10.36M | 8.06M | 12.96M | 11.62M | 25.76M | 12.01M | -41.91M | 19.64M | -12.43M |
| Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 104.19% | 100.00% | 100.00% | 77.63% | 77.37% | 69.21% | 59.84% | 59.66% | 73.61% | 71.10% | 78.22% | 61.27% | -71.14% | 73.42% | -64.34% |
| Research & Development | 15.56M | 20.25M | 14.54M | 9.49M | 6.48M | 9.77M | 11.14M | 9.89M | 5.94M | 2.48M | 256.41K | 5.40M | 3.90M | 8.09M | 18.79M | 18.80M | 16.15M | 12.02M | 10.18M | 8.21M | 8.22M | 7.86M | 0.00 | 5.93M | 3.60M |
| General & Administrative | 8.58M | 4.51M | 7.02M | 3.69M | 3.79M | 5.60M | 7.76M | 5.76M | 3.84M | 4.27M | 2.85M | 5.79M | 9.56M | 10.40M | 6.67M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 127.04K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.43M | 6.57M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.58M | 4.64M | 7.02M | 3.69M | 3.79M | 5.60M | 7.76M | 5.76M | 3.84M | 4.27M | 2.85M | 5.79M | 9.56M | 14.83M | 13.24M | 16.22M | 21.23M | 18.34M | 14.96M | 15.79M | 28.03M | 23.15M | 0.00 | 26.97M | 749.01K |
| Other Expenses | 555.00 | -10.00K | -2.00K | 968.00K | -9.00K | 3.67M | 8.43M | 2.87M | 1.54M | 341.99K | 6.03K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 24.15M | 24.88M | 21.56M | 13.16M | 10.25M | 14.69M | 18.76M | 15.64M | 9.68M | 6.74M | 3.11M | 11.19M | 13.46M | 22.92M | 32.40M | 35.02M | 37.38M | 30.36M | 25.13M | 24.01M | 36.26M | 31.01M | 0.00 | 33.29M | 5.69M |
| Cost & Expenses | 24.15M | 24.88M | 21.56M | 13.16M | 10.25M | 14.69M | 18.76M | 15.64M | 9.68M | 6.74M | 3.11M | 11.19M | 13.46M | 25.14M | 34.92M | 39.10M | 44.33M | 35.81M | 29.78M | 28.73M | 43.43M | 38.59M | 100.82M | 40.40M | 37.45M |
| Interest Income | 22.56K | 2.09K | 42.00K | 66.00K | 100.00K | 119.00K | 249.00K | 406.00K | 89.26K | 86.69K | 44.62K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.46M | 1.31M | 1.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 2.09K | 0.00 | 0.00 | 2.19M | 0.00 | 765.00K | 0.00 | 68.62K | 714.52K | 131.70K | 0.00 | 18.00K | 15.00K | 11.00K | 24.04K | 2.36K | 52.56K | 56.39K | 118.72K | 0.00 | 344.58K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -3.41M | 1.95M | 1.27M | 1.08M | 1.08M | 1.55M | 1.42M | 643.00K | 574.96K | 572.14K | 336.18K | 25.00K | 83.00K | 198.00K | 282.00K | 353.28K | 976.21K | 1.39M | 1.62M | 1.71M | 1.88M | 1.85M | 678.03K | 0.00 | 1.35M |
| EBITDA | -27.53M | -23.51M | -5.11M | -11.11M | -7.30M | -10.82M | -9.44M | -11.72M | -7.48M | -5.74M | -1.65M | -8.72M | -11.36M | -15.02M | -23.49M | -26.57M | -28.74M | -23.89M | -13.50M | -10.67M | -20.73M | -21.85M | -41.23M | -13.66M | -17.38M |
| EBITDA Ratio | -4,961,221.44% | -247,433.27% | -16.75% | -1,157.87% | -506.67% | -589.01% | -98.63% | -358.26% | -8,402.10% | -6,600.19% | -154.84% | -355.80% | -560.79% | -151.62% | -210.76% | -200.16% | -165.97% | -176.94% | -76.66% | -65.30% | -62.94% | -111.54% | -69.99% | -51.06% | -89.92% |
| Operating Income | -24.12M | -26.70M | -6.38M | -12.53M | -8.38M | -12.49M | -10.35M | -12.77M | -8.14M | -6.40M | -1.99M | -9.68M | -11.44M | -15.23M | -23.78M | -25.83M | -27.02M | -22.30M | -12.17M | -12.39M | -10.50M | -19.00M | -41.91M | -13.66M | -18.13M |
| Operating Income Ratio | -4,346,661.08% | -266,963.27% | -42.01% | -1,267.57% | -581.94% | -415.68% | -117.82% | -390.33% | -9,147.19% | -7,357.47% | -186.34% | -395.06% | -564.89% | -153.69% | -213.29% | -194.57% | -156.04% | -165.16% | -69.14% | -75.77% | -31.89% | -96.97% | -71.14% | -51.06% | -93.80% |
| Total Other Income/Expenses | 3.41M | 368.33K | -2.53M | -571.17K | -1.77M | 6.14M | -515.00K | 209.49K | 834.96K | -1.17M | 486.69K | 937.00K | 494.00K | -8.00K | -11.00K | 1.07M | 2.69M | 4.39M | -56.39K | 0.00 | 78.66K | 4.38M | -679.99K | 0.00 | 599.21K |
| Income Before Tax | -20.74M | -25.02M | -8.91M | -12.77M | -10.57M | -6.34M | -10.87M | -12.16M | -7.31M | -7.57M | -1.51M | -8.74M | -10.95M | -15.24M | -23.79M | -24.76M | -24.32M | -17.92M | -12.23M | 0.00 | -10.42M | -14.62M | -42.59M | -13.66M | -17.53M |
| Income Before Tax Ratio | -3,736,265.23% | -250,158.95% | -58.66% | -1,291.86% | -733.89% | -211.19% | -123.68% | -371.50% | -8,209.04% | -8,699.68% | -141.31% | -356.82% | -540.49% | -153.77% | -213.38% | -186.50% | -140.48% | -132.68% | -69.46% | 0.00% | -31.65% | -74.61% | -72.29% | -51.06% | -90.70% |
| Income Tax Expense | -271.09K | -368.08K | -484.00K | -298.00K | -298.00K | -305.00K | -199.00K | 2.77M | 1.44M | 955.10K | -339.62K | -9.11M | 1.00K | 10.00K | 1.00K | 4.18K | -1.18K | 1.35K | 2.62K | 117.29K | -7.42K | 44.41K | 58.79K | 21.77K | -1.05M |
| Net Income | -20.47M | -24.65M | -8.42M | -12.47M | -10.27M | -6.04M | -10.67M | -12.06M | -7.14M | -7.47M | -1.03M | 1.31M | -6.50M | -12.35M | -18.93M | -20.25M | -20.00M | -16.23M | -12.23M | -12.50M | -10.41M | -14.66M | -42.65M | -13.68M | -17.08M |
| Net Income Ratio | -3,687,419.82% | -246,478.15% | -55.47% | -1,261.70% | -713.19% | -201.03% | -121.41% | -368.66% | -8,020.89% | -8,583.13% | -96.58% | 53.43% | -320.89% | -124.60% | -169.80% | -152.55% | -115.53% | -120.15% | -69.47% | -76.49% | -31.63% | -74.83% | -72.39% | -51.14% | -88.37% |
| EPS | -0.11 | -0.19 | -0.07 | -0.17 | -0.18 | -0.12 | -0.02 | -0.28 | -0.30 | -0.48 | -0.09 | 0.13 | -0.64 | -1.21 | -1.86 | -2.08 | -2.05 | -1.67 | -1.26 | -1.26 | -1.08 | -1.54 | -4.98 | -1.61 | -3.00 |
| EPS Diluted | -0.11 | -0.19 | -0.07 | -0.17 | -0.18 | -0.12 | -0.02 | -0.28 | -0.30 | -0.48 | -0.09 | 0.13 | -0.64 | -1.21 | -1.86 | -2.08 | -2.00 | -1.67 | -1.26 | -1.13 | -1.08 | -1.54 | -4.98 | -1.61 | -3.00 |
| Weighted Avg Shares Out | 182.24M | 132.47M | 117.63M | 73.04M | 57.50M | 48.38M | 488.17M | 42.74M | 23.84M | 15.67M | 11.46M | 10.24M | 10.21M | 10.21M | 10.17M | 9.76M | 9.75M | 9.71M | 9.68M | 9.93M | 9.60M | 9.55M | 8.56M | 8.49M | 5.70M |
| Weighted Avg Shares Out (Dil) | 184.28M | 132.47M | 117.67M | 73.05M | 57.50M | 50.48M | 488.17M | 42.74M | 23.84M | 15.67M | 11.47M | 10.24M | 10.21M | 10.21M | 10.17M | 9.76M | 10.00M | 9.71M | 9.68M | 11.04M | 9.60M | 9.55M | 8.56M | 8.49M | 5.70M |
No news found for: KZA.AX
Source: https://incomestatements.info
Category: Stock Reports